Feline Sarcoma Virus (FeSV) is a retrovirus notorious for instigating sarcomas in cats, serving as a pivotal tool in cancer research. FeSV's knack for integrating its genetic material into the host's genome unleashes unchecked cell proliferation, culminating in tumor genesis. Investigation into FeSV has yielded profound insights into oncogenesis, tumor immunology, and therapeutic modalities. It serves as a potent model for unraveling the complexities of cancer biology, encompassing tumor initiation, progression, and metastasis. The exploration of FeSV's intricacies has catalyzed the innovation of groundbreaking cancer treatments and preventive vaccines, benefiting both feline and human cohorts. By deciphering the nuances of FeSV-induced oncogenesis, researchers strive to unveil overarching principles pivotal in combatting cancer across species domains.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States